Showing results (1541-1550 of 1,640) with videos related to

Sort By:
Pageof 164
Alzheimer Disease and Associated Disorders|March 18, 2014
Diagnostic criteria for vascular cognitive disorders: a VASCOG statementPerminder Sachdev, Raj Kalaria, John O'Brien, et al.
Trials|February 12, 2021
M.I.C.E-Mental Health Intervention for Children with Epilepsy: a randomised controlled, multi-centre clinical trial evaluating the clinical and cost-effectiveness of MATCH-ADTC in addition to usual care compared to usual care alone for children and young people with common mental health disorders and epilepsy-study protocolSophie D Bennett, J Helen Cross, Anna E Coughtrey, et al.
Science Advances|April 9, 2025
High-voltage water-scarce hydrogel electrolytes enable mechanically safe stretchable Li-ion batteriesPeisheng He, Jong Ha Park, Yingkai Jiao, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 22, 2025
Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community studiesWasiu G Balogun, Xuemei Zeng, Gallen Triana-Baltzer, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonistsBenjamin P Fauber, Alberto Gobbi, Kirk Robarge, et al.
Alzheimer'S Research & Therapy|July 27, 2025
Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohortMenayit Tamrat Dresse, Pamela C L Ferreira, Akshay Prasadan, et al.
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community cohortsWasiu G Balogun, Xuemei Zeng, Gallen Triana-Baltzer, et al.
Nature Cancer|January 3, 2025
Context-dependent effects of CDKN2A and other 9p21 gene losses during the evolution of esophageal cancerPiyali Ganguli, Celia C Basanta, Amelia Acha-Sagredo, et al.
Trials|November 26, 2021
The Reflective Fostering Programme-improving the wellbeing of children in care through a group intervention for foster carers: a randomised controlled trialNick Midgley, Karen Irvine, Beth Rider, et al.
Medrxiv : the Preprint Server for Health Sciences|May 9, 2025
Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohortMenayit Tamrat Dresse, Pamela C L Ferreira, Akshay Prasadan, et al.
Pageof 164